Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 119 participants.
Also called NCT06852079
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 119 participants
- Sponsor
- Abdul Bari
- Registry
-
NCT06852079
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT06852079. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-23 (actual); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
- Condition
- Hypertension
- Intervention (Other)
- Qurs e Fishar
- Lead sponsor
- Abdul Bari
- Collaborator
- Hamdard University
Record details
- Record id
cardio:ct-nct06852079- Content hash
f0adc4efbde7db4583c6a3b8908dbd429bca15a48f868c5c222942bdfb1968bd